moclobemide has been researched along with Somatoform Disorders in 2 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pirildar, S | 1 |
Sezgin, U | 1 |
Elbi, H | 1 |
Uyar, M | 1 |
Zileli, B | 1 |
Rütten, J | 1 |
1 trial available for moclobemide and Somatoform Disorders
Article | Year |
---|---|
A preliminary open-label study of moclobemide treatment of pain disorder.
Topics: Adult; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Moclobemide; Mon | 2003 |
1 other study available for moclobemide and Somatoform Disorders
Article | Year |
---|---|
[Moclobemide in treatment of somatoform depression. A case report].
Topics: Activities of Daily Living; Aged; Benzamides; Depressive Disorder; Female; Humans; Moclobemide; Mono | 1994 |